Sizheng Steven Zhao,Casper Webers,Elena Nikiphorou,Désirée van der Heijde,Jürgen Braun,Uta Kiltz,Sofia Ramiro,Annelies Boonen
{"title":"Disease activity and mental health symptoms in axial spondyloarthritis: concordant or discordant?","authors":"Sizheng Steven Zhao,Casper Webers,Elena Nikiphorou,Désirée van der Heijde,Jürgen Braun,Uta Kiltz,Sofia Ramiro,Annelies Boonen","doi":"10.1093/rheumatology/keaf506","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nWe applied latent class and trajectory modelling to examine whether subgroups of axial spondylarthritis (axSpA) patients report discordant scores for disease activity and mental health symptoms at baseline and after treatment change.\r\n\r\nMETHODS\r\nWe analysed axSpA patients from the ASAS Health Index International Validation Study. We applied latent class analysis (LCA) using generalized structural equation modelling to identify subgroups among 1292 individuals, based on baseline Hospital Anxiety and Depression Scale (HADS) subscores and ASDAS. We applied trajectory modelling in a subset (n = 206) requiring treatment change, to identify subgroups of distinct trajectories for HADS and ASDAS over 6 months. All indices were standardised. Baseline characteristics were compared across identified groups.\r\n\r\nRESULTS\r\nFor the baseline analysis, three groups were identified with concordant HADS subscores and ASDAS, with similar baseline characteristics except the high HADS/ASDAS group having more peripheral joint involvement and higher CRP levels. Trajectory analysis identified four groups with concordant HADS and ASDAS changes: 54% comparatively low baseline values, 33% medium and, of the high baseline groups, some (7%) had marked improvement (HADS-depression Δ11, HADS-anxiety Δ9, ASDAS Δ2.8), while others (6%) had limited ASDAS improvement (Δ1.4) with minimal changes in anxiety symptoms (Δ0.6).\r\n\r\nCONCLUSIONS\r\nWe did not identify the hypothesized subgroups with discordant disease activity and mental health symptoms. Instead, these domains were closely aligned at baseline and following treatment, suggesting that these symptoms influence each other. Patients with high mental health symptom burden may benefit from knowing that these symptoms often improve alongside disease activity when starting treatment.","PeriodicalId":21255,"journal":{"name":"Rheumatology","volume":"277 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/rheumatology/keaf506","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
We applied latent class and trajectory modelling to examine whether subgroups of axial spondylarthritis (axSpA) patients report discordant scores for disease activity and mental health symptoms at baseline and after treatment change.
METHODS
We analysed axSpA patients from the ASAS Health Index International Validation Study. We applied latent class analysis (LCA) using generalized structural equation modelling to identify subgroups among 1292 individuals, based on baseline Hospital Anxiety and Depression Scale (HADS) subscores and ASDAS. We applied trajectory modelling in a subset (n = 206) requiring treatment change, to identify subgroups of distinct trajectories for HADS and ASDAS over 6 months. All indices were standardised. Baseline characteristics were compared across identified groups.
RESULTS
For the baseline analysis, three groups were identified with concordant HADS subscores and ASDAS, with similar baseline characteristics except the high HADS/ASDAS group having more peripheral joint involvement and higher CRP levels. Trajectory analysis identified four groups with concordant HADS and ASDAS changes: 54% comparatively low baseline values, 33% medium and, of the high baseline groups, some (7%) had marked improvement (HADS-depression Δ11, HADS-anxiety Δ9, ASDAS Δ2.8), while others (6%) had limited ASDAS improvement (Δ1.4) with minimal changes in anxiety symptoms (Δ0.6).
CONCLUSIONS
We did not identify the hypothesized subgroups with discordant disease activity and mental health symptoms. Instead, these domains were closely aligned at baseline and following treatment, suggesting that these symptoms influence each other. Patients with high mental health symptom burden may benefit from knowing that these symptoms often improve alongside disease activity when starting treatment.
期刊介绍:
Rheumatology strives to support research and discovery by publishing the highest quality original scientific papers with a focus on basic, clinical and translational research. The journal’s subject areas cover a wide range of paediatric and adult rheumatological conditions from an international perspective. It is an official journal of the British Society for Rheumatology, published by Oxford University Press.
Rheumatology publishes original articles, reviews, editorials, guidelines, concise reports, meta-analyses, original case reports, clinical vignettes, letters and matters arising from published material. The journal takes pride in serving the global rheumatology community, with a focus on high societal impact in the form of podcasts, videos and extended social media presence, and utilizing metrics such as Altmetric. Keep up to date by following the journal on Twitter @RheumJnl.